000 04316nam a22004215i 4500
999 _c11744
_d11744
001 11744
003 DE-He213
005 20210727040328.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 180927s2018 gw | s |||| 0|eng d
020 _a9783319926575
024 7 _a10.1007/978-3-319-92657-5
_2doi
040 _bspa
_dES-VaUE
050 4 _aRD651
_b.A89 2018 EB
245 1 0 _aAtypical Breast Proliferative Lesions and Benign Breast Disease
_cedited by Farin Amersi, Kristine Calhoun.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _aXI, 197 p. 28 illus., 24 illus. in color.
_bonline resource
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 _aMedicine (Springer-11650)
505 0 _aThe Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors? -- Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor? -- Ductal Carcinoma In Situ: Risk Factor or Cancer -- Diagnostic Management of Papillomas, Radial Scars, and Flat Epithelial Atypia: Core Biopsy Alone Versus Core Biopsy Plus Excision -- Diagnostic Management of Fibroepithelial Lesions: When Is Excision Indicated? -- Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone vs Excisional Biopsy -- Diagnostic management of LCIS: Core biopsy alone versus core biopsy plus excision for classic versus pleomorphic LCIS -- Breast Cancer Risk Prediction in Women with Atypical Breast Lesions -- Advanced Screening Options and Surveillance in Women with Atypical Breast Lesions -- The Role of Chemoprevention in the Prevention of Breast Cancer -- Prophylactic Mastectomy in Patients with Atypical Breast Lesions -- The Non-surgical Management of Ductal Carcinoma in Situ (DCIS) -- Surgical Treatment of Ductal Carcinoma in Situ. .
520 _aThe days of surgical excision for any atypical lesion have been replaced by more nuanced decision making and individualized patient management. Current management of many of these lesions continues to be controversial in regard to observation with close surveillance versus the need for surgical excision of these lesions based on future risk or whether these lesions are precursor lesion. The goal of this book is to provide a concise but comprehensive review of atypical breast proliferative lesions and their management complexities. New data about breast cancer, risk factors for breast cancer, pathological features unique to each entity, the characteristic findings on imaging, risk stratification for genetic testing, as well as the current evidence-based management of each of these breast lesions are discussed in full detail. Assessment tools for risk prediction of breast cancer are also highlighted as chapters run the gamut of current imaging modalities, as well as advanced screening options available for diagnosis and following these patients. Atypical Breast Proliferative Lesions and Benign Breast Disease will undoubtedly become a valuable resource for nurse practitioners, physician assistants, breast and surgical oncology fellows, genetic counselors, geneticists, as well as other clinicians and surgeons who are referred and manage these complex breast patients. All chapters in this text are written by experts in the field who have research and clinical interest in each of these disease entities, and include the most up-to-date research and clinical information to enhance our understanding and treatment of patients.
653 0 _aSurgery.
653 0 _aSurgical oncology.
653 0 _aOncology  .
653 0 _aPathology.
700 1 _aAmersi, Farin.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aCalhoun, Kristine.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
776 0 8 _iPrinted edition:
_z9783319926568
776 0 8 _iPrinted edition:
_z9783319926582
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-92657-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0